DUAL REGULATION OF PANCREATIC VASCULAR TONE BY P2X AND P2Y PURINOCEPTOR SUBTYPES

被引:19
作者
HILLAIREBUYS, D
CHAPAL, J
PETIT, P
LOUBATIERESMARIANI, MM
机构
[1] Faculté de Médecine, Laboratoire de Pharmacologie, Unité de Recherche Associée 599, Montpellier
关键词
ATP; VASOCONSTRICTION; VASODILATATION; P2-PURINOCEPTORS; PANCREAS (ISOLATED); (RAT);
D O I
10.1016/0014-2999(91)90494-B
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of ATP on the pancreatic vascular bed of the rat were studied under resting tone. ATP exerted two different effects depending on the concentration used: a slight vasodilatation in the 1.65-49.5-mu-M range which was statistically significant only at 16.5-mu-M and a concentration-related vasoconstriction in the 495-4 950-mu-M range. Theophylline, a P1 purinoceptor antagonist, did not modify the vasodilator effect of ATP. The existence of two P2 purinoceptor subtypes (P2y and P2x) in our preparation may be responsible for the dual effect of ATP. The P2y antagonist 2,2'-pyridylisatogen (PIT) used at 5-mu-M, revealed a vasoconstrictor effect of ATP 165-mu-M, a concentration without effect per se. Furthermore, the transient vasoconstrictor effect of ATP 495-mu-M was changed into a long-lasting one in the presence of PIT. On the other hand, the blockade of P2x purinoceptors by the desensitizing agent, alpha,beta-methylene ATP, increased the vasodilator effect of ATP 16.5-mu-M. In conclusion, two subtypes of P2 purinoceptor do exist on the pancreatic vascular bed: P2y inducing vasodilatation and P2x inducing vasoconstriction. At vascular resting tone, the effect observed with ATP therefore depends on the concentration used and on the balance between P2y/P2x purinoceptors.
引用
收藏
页码:309 / 314
页数:6
相关论文
共 29 条
[11]   PURINERGIC RECEPTORS - PHOTOAFFINITY ANALOG OF ADENOSINE-TRIPHOSPHATE IS A SPECIFIC ADENOSINE-TRIPHOSPHATE ANTAGONIST [J].
HOGABOOM, GK ;
ODONNELL, JP ;
FEDAN, JS .
SCIENCE, 1980, 208 (4449) :1273-1276
[12]  
HOOPER M, 1979, PHYSL REGULATORY FUN, P85
[13]  
KASAKOV L, 1983, European Journal of Pharmacology, V86, P291
[14]   EVIDENCE FOR 2 TYPES OF P2-PURINOCEPTOR IN LONGITUDINAL MUSCLE OF THE RABBIT PORTAL-VEIN [J].
KENNEDY, C ;
BURNSTOCK, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 111 (01) :49-56
[15]  
LONG CJ, 1985, BLOOD VESSELS, V22, P205
[16]   EXPERIMENTAL STUDY ON GLIBENCLAMIDE (HB 419) A NEW PARTICULARLY ACTIVE HYPOGLYCAEMIC SULPHONAMIDE .I. BETA-CYTROTROPIC ACTION AND INSULIN SECRETION [J].
LOUBATIE.A ;
MARIANI, MM ;
RIBES, G ;
DEMALBOS.H ;
CHAPAL, J .
DIABETOLOGIA, 1969, 5 (01) :1-&
[17]   AN ELECTROPHYSIOLOGICAL ANALYSIS OF THE EFFECT OF REACTIVE BLUE-2, A PUTATIVE P-2-PURINOCEPTOR ANTAGONIST, ON INHIBITORY JUNCTION POTENTIALS OF RAT CECUM [J].
MANZINI, S ;
HOYLE, CHV ;
BURNSTOCK, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 127 (03) :197-204
[18]   PURINE-MEDIATED RELAXATION AND CONSTRICTION OF ISOLATED RABBIT MESENTERIC-ARTERY ARE NOT ENDOTHELIUM-DEPENDENT [J].
MATHIESON, JJI ;
BURNSTOCK, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 118 (03) :221-229
[19]  
PEARSON JD, 1989, BIOCHEM PHARMACOL, V38, P57
[20]   ACTIONS MEDIATED BY P2-PURINOCEPTOR-SUBTYPES IN THE ISOLATED PERFUSED MESENTERIC BED OF THE RAT [J].
RALEVIC, V ;
BURNSTOCK, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 95 (02) :637-645